BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16357092)

  • 1. Comments on Women, hormones, and clinical trials: a beginning, not an end.
    Minson CT; Kaplan P; Meendering JR; Torgrimson BN; Miller NP
    J Appl Physiol (1985); 2006 Jan; 100(1):373. PubMed ID: 16357092
    [No Abstract]   [Full Text] [Related]  

  • 2. Women, hormones, and clinical trials: a beginning, not an end.
    Miller VM; Clarkson TB; Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Naftolin F; Santoro N
    J Appl Physiol (1985); 2005 Aug; 99(2):381-3. PubMed ID: 16020431
    [No Abstract]   [Full Text] [Related]  

  • 3. Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future.
    Clarkson TB; Meléndez GC; Appt SE
    Menopause; 2013 Mar; 20(3):342-53. PubMed ID: 23435033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
    Salpeter S
    Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of combined estrogen-androgen preparations in the postmenopause: evidence from clinical studies.
    Sherwin BB
    Int J Fertil Womens Med; 1998; 43(2):98-103. PubMed ID: 9609209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy update. How to make sense of the new recommendations on postmenopausal hormone therapy.
    Harv Womens Health Watch; 2013 Mar; 20(7):3. PubMed ID: 23862210
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone therapy: a new consensus.
    Harv Womens Health Watch; 2012 Oct; 20(2):8. PubMed ID: 23193635
    [No Abstract]   [Full Text] [Related]  

  • 11. Women's cognitive health: postmenopausal dementia and the women's health initiative memory study.
    Klein KP; Rapp SR
    Womens Health Issues; 2004; 14(3):71-4. PubMed ID: 15193634
    [No Abstract]   [Full Text] [Related]  

  • 12. Menopausal hormone replacement therapy.
    Varner RE
    Curr Womens Health Rep; 2003 Oct; 3(5):410-7. PubMed ID: 12959701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone replacement: historical perspectives and current concerns.
    White JP; Schilling JS
    Clin Excell Nurse Pract; 2000 Sep; 4(5):277-85. PubMed ID: 11858449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk associated with hormone replacement therapy: some critical questions about the type of estrogen used in most clinical trials.
    Subbiah MT
    Atherosclerosis; 2004 Apr; 173(2):373-4. PubMed ID: 15064116
    [No Abstract]   [Full Text] [Related]  

  • 15. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.
    Sitruk-Ware R
    Climacteric; 2007 Oct; 10(5):358-70. PubMed ID: 17852138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and coronary artery disease.
    Morris D
    Curr Opin Obstet Gynecol; 1996 Jun; 8(3):184-7. PubMed ID: 8818528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen therapy in older patients with recurrent urinary tract infections: a review.
    Rozenberg S; Pastijn A; Gevers R; Murillo D
    Int J Fertil Womens Med; 2004; 49(2):71-4. PubMed ID: 15188831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].
    Henriksson P
    Lakartidningen; 2002 Nov; 99(47):4716-9. PubMed ID: 12523045
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone replacement therapy: a time for pause.
    Yusuf S; Anand S
    CMAJ; 2002 Aug; 167(4):357-9. PubMed ID: 12197690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.